Archive for October, 2009

Geron hopes to restart stem-cell study in 2010

Biotechnology company Geron Corp. said Friday it hopes to pave the way for restarting human studies on a potential stem-cell treatment for spinal cord injury by conducting additional preclinical studies.

Michigan Senate aims to ignore people on stem-cell research

LANSING – A year ago, the most intense campaign in Michigan was not the race for the presidency but the battle over whether to change the state constitution to allow research using stem cells taken from human embryos created in fertility clinics …

Integrity Media: Stem Cell Report Released

LAS VEGAS — A Murphy Analytics report and profile featuring BrainStorm and detailing its achievements in stem cell research has been released. This report is of potential interest to investors of leading stem cell equities Geron , Osiris Therapeutics , Aastrom Biosciences and StemCells .

The Promise, the Hype, and the Reality: It’s a Different Perceptual Era for Embryonic Stem Cell Research [Framing …

Over at the Knight Science Tracker , Charlie Petit has a round-up on news coverage of the California Institute for Regenerative Medicine’s first significant research grants for stem cell research. Though much of the focus in California and nationally has obviously been on the promise of embryonic stem cell research, only four of the 14 funded projects involve these type of stem cells. The …

Judge Dismisses Lawsuit Challenging Federal Guidelines On Embryonic Stem Cell Research

U.S. District Judge Royce Lamberth on Tuesday dismissed a lawsuit challenging the Obama administration’s move this year to ease federal restrictions on embryonic stem cell research, the AP/Seattle Times reports. In its lawsuit, Nightlight Christian Adoptions alleged that the new federal guidelines would reduce the availability of human embryos for adoptions.

Of Mice And Men: Stem Cells And Ethical Uncertainties

The recent creation of live mice from induced pluripotent stem cells (iPSCs) not only represents a remarkable scientific achievement, but also raises important issues, according to bioethicists at The Johns Hopkins University’s Berman Institute of Bioethics. In a letter published Oct. 28 in Regenerative Medicine, the authors advocate for clear ethical oversight of this research and pose key questions that warrant careful consideration.

Black Sabbath’s Tony Iommi hopes stem cell treatment will help him get his groove back

Black Sabbath guitarist Tony Iommi is undergoing stem cell treatment after repetitive strain injury left him struggling to play his famous riffs.

Recovery Act Funds Expand Studies Of Stem Cell Biology

The National Institute of General Medical Sciences (NIGMS), part of the National Institutes of Health, is using $5.4 million of Recovery Act funds to accelerate basic studies of induced pluripotent stem cells. These cells, abbreviated iPS, are reprogrammed from skin or other easily obtained adult cells and appear to be similar to stem cells derived from embryos.

PUrsuing Novel Stem-Cell Derived Therapy For Lou Gehrig’s Disease With $10.8 Million Award

The Salk Institute has been awarded a $10.8 million grant by the California Institute for Regenerative Medicine (CIRM) for translational research focusing on developing a novel stem-cell based therapy for Amyotrophic Lateral Sclerosis (ALS) – or Lou Gehrig’s Disease. Sam Pfaff, Ph.D.

Panel debates laws about stem cells

Lansing — Embryonic stem cell research supporters are worried legislation debated in a state Senate committee Wednesday could threaten the progress of research in Michigan. The bills discussed in the Senate Health Policy Committee would establish …